Catherine Wood's RXRX Position Overview
Catherine Wood (via ARK Investment Management LLC) currently holds 33.5M shares of Recursion Pharmaceuticals, Inc. (RXRX) worth $163.7 M, representing 0.97% of the portfolio. First purchased in 2021-Q2, this medium-term investment has been held for 18 quarters.
Based on 13F filings, Catherine Wood has maintained a strategic position in RXRX, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2023, adding 13.8M shares. Largest reduction occurred in Q2 2025, reducing 1.8M shares.
Analysis based on 13F filings available since 2013 Q2
Catherine Wood's Recursion Pharmaceuticals (RXRX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Recursion Pharmaceuticals (RXRX) Trades by Catherine Wood
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|
Catherine Wood's Recursion Pharmaceuticals Investment FAQs
Catherine Wood first purchased Recursion Pharmaceuticals, Inc. (RXRX) in Q2 2021, acquiring 2,378,675 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Catherine Wood has held Recursion Pharmaceuticals, Inc. (RXRX) for 18 quarters since Q2 2021. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Catherine Wood's largest addition to Recursion Pharmaceuticals, Inc. (RXRX) was in Q4 2023, adding 20,654,287 shares worth $203.65 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Catherine Wood's firm, ARK Investment Management LLC, owns 33,545,499 shares of Recursion Pharmaceuticals, Inc. (RXRX), valued at approximately $163.7 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Recursion Pharmaceuticals, Inc. (RXRX) represents approximately 0.97% of Catherine Wood's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Catherine Wood's peak holding in Recursion Pharmaceuticals, Inc. (RXRX) was 34,815,502 shares, as reported at the end of Q1 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.